DocGo (NASDAQ:DCGO) Sets New 1-Year High – Time to Buy?

DocGo Inc. (NASDAQ:DCGO)’s share price reached a new 52-week high on Friday . The company traded as high as $4.91 and last traded at $4.94, with a volume of 432578 shares changing hands. The stock had previously closed at $4.48.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC restated a “buy” rating and issued a $7.00 target price on shares of DocGo in a report on Thursday, January 16th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $6.10.

DocGo Trading Up 10.3 %

The firm has a market capitalization of $504.13 million, a P/E ratio of 17.64, a P/E/G ratio of 12.36 and a beta of 0.97. The stock’s 50-day simple moving average is $4.26 and its 200-day simple moving average is $3.75.

DocGo (NASDAQ:DCGO) last announced its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The firm had revenue of $138.68 million for the quarter, compared to the consensus estimate of $139.59 million. DocGo had a return on equity of 8.90% and a net margin of 4.35%. During the same quarter in the previous year, the business earned $0.05 EPS. On average, equities research analysts expect that DocGo Inc. will post 0.25 EPS for the current year.

Insider Buying and Selling at DocGo

In other news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now directly owns 175,645 shares in the company, valued at $779,863.80. The trade was a 11.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 2.70% of the company’s stock.

Institutional Trading of DocGo

A number of large investors have recently added to or reduced their stakes in the stock. Centiva Capital LP purchased a new position in DocGo in the third quarter valued at about $43,000. Intech Investment Management LLC purchased a new position in DocGo in the third quarter valued at approximately $62,000. The Manufacturers Life Insurance Company lifted its stake in DocGo by 31.6% in the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after purchasing an additional 9,696 shares during the last quarter. SG Americas Securities LLC increased its position in DocGo by 97.5% in the third quarter. SG Americas Securities LLC now owns 38,147 shares of the company’s stock worth $127,000 after buying an additional 18,835 shares during the last quarter. Finally, Victory Capital Management Inc. raised its stake in shares of DocGo by 100.3% in the third quarter. Victory Capital Management Inc. now owns 51,349 shares of the company’s stock valued at $170,000 after buying an additional 25,714 shares during the period. Hedge funds and other institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.